Search Altweb

Advances in In-Vitro Cell and Tissue Culture and 5th Annual Quasi-Vivo User Group Meeting

May 21-22, 2013
Liverpool, United Kingdom

Program

Day 1 – Tuesday, May 21st

9.30-10.00
Registration

10.00
Welcome address by Professor John Hunt and Dr Malcolm Wilkinson

Session 1 : Industry Overview - Chair, (Dr. Judith Curran)

10.15
Opening Keynote
Thomas Hartung, MD PhD (Doerenkamp-Zbinden Professor
and Chair for Evidence-based Toxicology Johns Hopkins University, USA)
Are our cell cultures good enough for regulatory decision taking?

11.00
Terry McCann (Pharma Industry specialist)
Do 3D culture and perfusion systems provide real advantages for drug screening and disease modelling? A review of the current state-of-the-art.

11.30-11.45
Coffee Break

11.45
Keynote
Andrew Bennett FRAME Laboratory Nottingham

12.15
Francois Busquet CAAT
EU policy program and horizon 2020

12.35
Arti Ahluwalia, Centro Piaggio, Pisa
(Creating physiologically relevant cell culture environment?)

13.00
Closing session comments and questions

13.00
LUNCH at the venue – poster and exhibitor viewing

Session 2 : Advances in Cell Supply - Chair, (Dr Nicholas Rhodes)

14.00
Welcome introduction from the Chair

14.00
Keynote
Maureen Bunger, Cellular Dynamics International, USA
Induced Pluripotent Stem Cell-derived Model Systems: Applications for Predictive and Mechanistic Toxicology in vitro

14.30
Samuel Constant, Epithelix, Geneva
In-vitro Cellular Assay for Identification of Respiratory Chemical Sensitizers based on Human 3D Epithelium Model (MucilAir™)

14.50
Open Papers

15.15-15.30
Coffee Break

15.30
Keynote
Patricia Murray, ITM, University of Liverpool

16.00
Sponsors/exhibitor showcase (mini presentations)

17.00
Closing session comments and questions

17.00-18.00
Exhibitor/Poster viewing

19.00
Conference Dinner and Drinks Reception at (Venue)

Day 2 – Wednesday, May 22nd

Session 3 : Applications Session 1 - Chair, (Dr Nicholas Bryan)

9.00
Welcome introduction from the Chair

9.00
Keynote
Paul A. De Sousa, PI-Pluripotent Stem Cell Translation lab, Centre for Regenerative Medicine, University of Edinburgh.
Manufacturing a stem cell niche for human embryonic stem cell manufacturing

9.30
Shaheda Ahmed, Alcyomics Ltd, Newcastle
Human (Non 3D equivalent) skin assays for detection of adverse reactions, potency and efficacy

9.55
Open Papers

10.25
Closing session comments and questions

10.30
Coffee break

Session 4 : Bioreactors and Scaffolds - Chair (TBA)

10.50
Welcome introduction from the Chair

11.00
Keynote
Professor Alicia El Haj, Director ISTM Keele University

11.30
Don Wellings Spheritech Ltd
(Scaffolds for kidney cells, retinal cells and nerve regeneration?)

11.50
Amir GhaemMaghami, Nottingham University
(Immuno-competant lung model?)

12.10
Open Paper

12.30
LUNCH at the venue – poster and exhibitor viewing

Session 5 : Applications Session 2– Chair, (TBA)

13.30
Keynote
Professor Andreas K. Nüssler, Medicyte Heidelberg
Evaluation of a chip-based 3D system for the use of primary human hepatocytes and Huh-7 cell line in drug toxicity testing

14.00
Kelly Berube, Cardiff University
NHBE and Metabo-Lung™ Models: Normal and Metabolising 3-Dimensional In Vitro Alternatives for Lung Research

14.20
Carole Mathis, Philip Morris International, Neuchatel
(Co- culture models for toxicity screening?)

14.40
Open Paper

15.00
Comments and Questions

15.15
Coffee/tea break

15.45
Keynote
Bill Greenhalf Royal Liverpool University Hospital

16.15
Closing comments and round-up
Malcolm Wilkinson and Professor John Hunt

16.30
Meeting ends

For more information see the UK Centre for Tissue Engineering Webpage.
PDF of program.